Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
CNS & Neurological Disorders Drug Targets|May 1, 2022
Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective StudyUmut Safer, Mehmet Ilkin Naharci, Ilker Tasci, et al.Journal of Clinical Ultrasound : JCU|August 30, 2025
Ultrasonographic Geniohyoid Muscle Measurements and Their Relationship With Quality of Life and Functional Outcomes in Older Patients With StrokeVildan Binay Safer, Nezahat Muge Catikkas, Aysegul Gultekin, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 31, 2016
Effects of Bisphosphonates and Calcium plus Vitamin-D Supplements on Cognitive Function in Postmenopausal Osteoporosis§Umut Safer, Vildan Binay Safer, Sibel Ozbudak Demir, et al.Turkish Journal of Physical Medicine and Rehabilitation|August 8, 2020
Low bone density and osteoporosis among older adults with Alzheimer's disease, vascular dementia, and mixed dementia: A Cross-sectional Study With Prospective EnrollmentBilgin Başgöz, Semra İnce, Umut Safer, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|December 27, 2018
Age at First Osteoporosis Screening Among Older Women and Men: Is Bone Mineral Density Measurement Ordered Timely?Ilker Tasci, Bilgin Bahadir Basgoz, Umit Cintosun, et al.American Journal of Alzheimer'S Disease and Other Dementias|August 9, 2017
Undetected Peripheral Arterial Disease Among Older Adults With Alzheimer's Disease and Other DementiasIlker Tasci, Umut Safer, Mehmet Ilkin Naharci, et al.Acta Clinica Belgica|December 19, 2017
Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up studyIlker Tasci, Umit Cintosun, Umut Safer, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|November 5, 2015
Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with OsteoporosisIlker Tasci, Umut Safer, Umit Cintosun, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|July 16, 2013
Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetesIlker Tasci, Mehmet Ilkin Naharci, Ergun Bozoglu, et al.Endocrine|October 21, 2010
Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitusAlper Sonmez, Cem Haymana, Serkan Tapan, et al.Pageof 2